Showing results (61-70 of 895) with videos related to

Sort By:
Pageof 90
Expert Opinion on Pharmacotherapy|March 16, 2001
RofecoxibJ L Hillson, D E Furst
The Journal of Rheumatology. Supplement|May 1, 1997
Hypothesis for the pathogenesis of systemic sclerosisD E Furst, P J Clements
Clinics in Geriatric Medicine|May 25, 2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Rheumatic Diseases Clinics of North America|July 27, 2015
Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic ApproachesElizabeth R Volkmann, Daniel E Furst
Expert Review of Clinical Immunology|July 11, 2017
Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic reviewAly M Aly, Daniel E Furst
Rheumatic Diseases Clinics of North America|November 15, 1997
Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and designJ L Hillson, D E Furst
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Problems encountered during anti-tumour necrosis factor therapySheetal B Desai, Daniel E Furst
The Journal of Rheumatology. Supplement|May 1, 1997
The evolving role of blood and marrow transplantation for the treatment of autoimmune diseasesK M Sullivan, D E Furst
Current Opinion in Rheumatology|November 1, 2002
Stem cell therapy in sclerodermaYolanda Braun-Moscovici, Daniel E Furst
Pageof 90